Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Temazepam
Teva B.V.
N05CD; N05CD07
Temazepam
20 milligram(s)
Tablet
Product subject to prescription which may not be renewed (A)
Benzodiazepine derivatives; temazepam
Marketed
1993-12-13
NORTEM 10 MG TABLETS NORTEM 20 MG TABLETS temazepam PACKAGE LEAFLET: INFORMATION FOR THE USER READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. WHAT NORTEM TABLETS ARE AND WHAT THEY ARE USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE NORTEM TABLETS 3. HOW TO TAKE NORTEM TABLETS 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE NORTEM TABLETS 6. CONTENTS OF THE PACK AND FURTHER INFORMATION 1. WHAT NORTEM TABLETS ARE AND WHAT THEY ARE USED FOR Nortem Tablets contain temazepam as the active ingredient. Temazepam is an anti-anxiety drug which is used in the short-term to help people sleep. It belongs to a group of drugs called benzodiazepines. Nortem Tablets are used for: • short-term treatment of insomnia (difficulty in sleeping) which is severe, disabling or causing extreme distress • pre-medication before minor surgery or other procedures. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE NORTEM TABLETS DO NOT TAKE NORTEM TABLETS IF YOU: • are allergic to temazepam or other benzodiazepines (e.g. diazepam) or any of the other ingredients of this medicine • have difficulty in breathing or lung problems • have a condition called sleep apnoea syndrome (where breathing stops during sleep) • have myasthenia gravis (a condition where the muscles become weak and tire easily) • have severe liver problems WARNINGS AND PRECAUTIONSTALK TO YOUR DOCTOR BEFORE YOU START TO TAKE THIS MEDICINE IF YOU: • have long-term lung problems (taking Nortem Tablets may cause fatal breathing problems) • have kidney problems • have li Read the complete document
Health Products Regulatory Authority 26 January 2022 CRN00CQPM Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Nortem 20mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 20 mg of temazepam. Excipient(s) with known effect Each tablet contains 280.0 mg lactose. For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Tablet White to pale yellow, flat bevel-edged tablets with a breakline on one side, 5K2 on reverse. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS As a hypnotic for the short-term management of insomnia only when it is severe, disabling or subjecting the individual to extreme distress. For pre-medication prior to minor surgery or other related procedures. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Oral. The treatment period should be of the shortest duration possible. This may vary from a few days to two weeks with a maximum (including tapering off) of four weeks. The dose reduction process should be tailored to the individual. In certain cases extension beyond the maximum treatment period may be necessary; if this is the case it should not take place without re-evaluation of the patient's status. The product should be taken on retiring or up to 30 minutes before going to bed. DOSAGE Insomnia Adults: 10 ‑ 20 mg. In exceptional circumstances, the dose may be increased to 30 ‑ 40 mg. Elderly: 10 mg. In exceptional circumstances, the dose may be increased to 20 mg. Pre-medication: The usual dose is 20 ‑ 40 mg 30 to 60 minutes before the procedure. Children: Not recommended for use in children. Treatment should be started with the lowest, recommended dose. The maximum dose should not be exceeded. Patients suffering from renal or hepatic impairment should receive a reduced dose. 4.3 CONTRAINDICATIONS Myasthenia Gravis. Severe respiratory insufficiency. Health Products Regulatory Authority 26 January 2022 CRN00CQPM Page 2 of 7 Sleep apnoea syndrome. Severe hepatic insufficiency. Nortem Tablets are contraindicated in patients with hy Read the complete document